MyFinsight
Home
Blog
About
Contact
Download
Download image
Exercise of warrants
$174,375
Net cash provided by
(used in) financing...
$147,823
Canceled cashflow
$26,552
Net decrease in cash
-$3,008,766
Canceled cashflow
$147,823
Inventory
-$560,658
Stock-based compensation
$359,255
Amortization and
depreciation
$65,523
Non-cash lease expense
$28,944
Deferred issuance costs
in connection with...
$22,920
Share repurchases for
the payment of...
$3,632
Net cash (used in)
provided by operating...
-$3,115,835
Canceled cashflow
$1,014,380
Net cash used in
investing activities
-$40,754
Net (loss) income
-$1,437,890
Accounts receivable
$1,397,062
Accrued expenses,
operating leases and other...
-$619,376
Accounts payable
-$439,992
Fair value change in
warrant liability
-$222,740
Prepaid expenses
$13,155
Purchase of property and
equipment
$40,754
Back
Back
Cash Flow
source: myfinsight.com
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)